AML Classification Tool

Share

Disclaimer: The information provided in this application is for educational and informational purposes only. For medical advice, please consult a qualified healthcare professional.

References:

Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022 Sep 22;140(12):1345–77.

Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022 Jul;36(7):1703–19.

For additional information about specific mutations, consider using OncoKB.

Clinical History:
MDS or MDS/MPN
Chemo/radiation
Germline predisposition
Associated with Down Syndrome